Bioequivalence (bioavailability) of generic topical corticosteroids

Area of Science:

• Dermatology
• Pharmacology
• Pharmaceutical Sciences

Background:

• Topical corticosteroids are widely prescribed for dermatological conditions.
• Generic substitution is common, raising concerns about product bioavailability and therapeutic equivalence.
• Existing methods for assessing topical corticosteroid bioavailability may lack quantitative precision.

Purpose of the Study:

• To quantitatively assess the bioavailability of generic topical corticosteroid products.
• To compare the bioavailability of betamethasone valerate 0.1% cream and triamcinolone 0.1% cream.
• To evaluate the implications of generic substitution on therapeutic outcomes.

Main Methods:

• A novel, quantitative vasoconstrictor assay was developed and employed.
• Bioavailability of betamethasone valerate 0.1% cream and triamcinolone 0.1% cream was measured.
• A survey of local pharmacies was conducted to determine generic substitution rates.

Main Results:

• Betamethasone valerate 0.1% cream products exhibited two distinct bioavailability categories.
• Triamcinolone 0.1% cream products demonstrated three distinct activity categories.
• Generic substitution rates were high: 58% for betamethasone valerate and 75% for triamcinolone acetonide.

Conclusions:

• Significant variability exists in the bioavailability of generic topical corticosteroid products.
• The prevalence of generic substitution necessitates standardization of topical product bioavailability.
• Ensuring consistent bioavailability is crucial for predictable therapeutic efficacy of topical corticosteroids.